Literature DB >> 25169555

Epidemiological assessment of leukemia in Kazakhstan, 2003- 2012.

Nurbek Igissinov1, Dariyana Kulmirzayeva, Malcolm A Moore, Saginbek Igissinov, Gulnara Baidosova, Gulnur Akpolatova, Zhanar Bukeyeva, Yelvira Omralina.   

Abstract

Cancer is a major health problem facing the entire world, and Kazakhstan is not the exception. The aim of this study was to present an epidemiological assessment of leukemia in the population of Kazakhstan during 2003-2012. This descriptive and retrospective study was based on data obtained from all oncological organizations of the whole country. Age standardized incidence rates per 100,000 population for leukemia were calculated. Totally, 6,741 new cases of leukemia were registered in Kazakhstan during the 10 year period. The mean age of patients with leukemia was 48.5. The ASRs for leukemia among men and women were 5.3 and 3.6, respectively (p<0.001). In conclusion, our results showed a high incidence rate of leukemia in Kazakhstan, especially in the north of the country. The incidence of leukemia was significantly higher in males and increased with age. Determining and controlling important risk factors of leukemia may lead to decrease in its burden.

Entities:  

Mesh:

Year:  2014        PMID: 25169555     DOI: 10.7314/apjcp.2014.15.16.6969

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Leukemia-Related Mortality in Inner Mongolia, 2008-2012.

Authors:  Zhihui Hao; Yongsheng Chen; Yongjun Xu; Maolin Du; Ying Wang; Qing Zhang; Heixiao Bai; Sun Juan
Journal:  Glob J Health Sci       Date:  2015-11-18

2.  Plasma 25-Hydroxyvitamin D Levels and VDR Gene Expression in Peripheral Blood Mononuclear Cells of Leukemia Patients and Healthy Subjects in Central Kazakhstan.

Authors:  Assel G Zhumina; Konstantin Li; Anna A Konovalova; Yelena A Li; Margarita Yu Ishmuratova; Gayane P Pogossyan; Michael Danilenko
Journal:  Nutrients       Date:  2020-04-26       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.